- $7.90bn
- $9.12bn
- $3.78bn
Brief: Aptar Reports Fourth Quarter And Annual 2022 Results
Brief: Aptar Reports Q4 Sales $796 Million
Aptargroup Inc expected to post earnings of 79cents a share - Earnings Preview
Brief: Aptar Pharma Launches First Metal-Free Nasal Spray Pump
Brief: Aptar Announces Realignment Of Two Of Its Business Reporting Segments
Aptargroup Inc reports results for the quarter ended in September - Earnings Summary
Brief: Aptar Reports Third Quarter 2022 Results
Aptargroup Inc expected to post earnings of 94cents a share - Earnings Preview
JPMorgan Inv. Trusts - Ten Largest Investments
Brief: Aptar Announces Exclusive Collaboration Between Aptar Pharma And Fluidda
JPMorgan Inv. Trusts - Ten Largest Investments
Brief: Aptar Appoints Matthew Trerotola To Its Board Of Directors
JPMorgan Inv. Trusts - Ten Largest Investments
Aptargroup Inc reports results for the quarter ended in June - Earnings Summary
Brief: Aptar Reports Second Quarter 2022 Results
Aptargroup Inc expected to post earnings of 96 cents a share - Earnings Preview
JPMorgan Inv. Trusts - Ten Largest Investments
JPMorgan Inv. Trusts - Ten Largest Investments
NYSE ORDER IMBALANCE 63186.0 SHARES ON SELL SIDE